Khanyile, Richard
Steve Biko Hospital
2 papers on CoChat
Most cited papers
- Verified
Abstract CT036: Bioavailability of MK-3475A (pembrolizumab with berahyaluronidase alfa; “subcutaneous pembrolizumab”) in participants with advanced or metastatic solid tumors
Torras, O. R., Cohen, G., Cho, B. C., Rojas, C., Walton, C., Medina, L., Khanyile, R., Papai, Z., Lala, M., Song, G., et al. (2025) · Cancer Research
Cancer Immunotherapy and BiomarkersBiosimilars and Bioanalytical Methods
Cited by 3
- Verified
Abstract CT035: Pharmacokinetics (PK), safety, and tolerability of pembrolizumab with berahyaluronidase alfa administered subcutaneously Q3W in participants with advanced melanoma
Coetzee, C., Khanyile, R., Cohen, G., McAdam, G., Walton, C., Chan, S. W., Rapoport, B., Caglevic, C., Yañez, P., Lala, M., et al. (2025) · Cancer Research
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free